Mimedx (MDXG) EBIT (QoQ) (2011 - 2026)
Mimedx (MDXG) EBIT (QoQ) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Mimedx |
546.28 Mn |
386.51 Mn |
41.62 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-176.14% |
| Dec 31, 2025 |
-5.02% |
| Sep 30, 2025 |
79.39% |
| Jun 30, 2025 |
49.92% |
| Mar 31, 2025 |
-25.36% |
| Dec 31, 2024 |
-0.97% |
| Sep 30, 2024 |
-52.40% |
| Jun 30, 2024 |
77.68% |
| Mar 31, 2024 |
-14.80% |
| Dec 31, 2023 |
39.25% |
| Sep 30, 2023 |
2.63% |
| Jun 30, 2023 |
3,287.94% |
| Mar 31, 2023 |
-103.01% |
| Dec 31, 2022 |
259.24% |
| Sep 30, 2022 |
26.29% |
| Jun 30, 2022 |
-3.61% |
| Mar 31, 2022 |
-823.74% |
| Dec 31, 2021 |
219.53% |
| Sep 30, 2021 |
-162.20% |
| Jun 30, 2021 |
94.02% |
